| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ee8281dc8e22676c5fcc97eb4ae2f61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_171a9d4f748ac633b3b77d02286d6e54 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-347
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C279-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-175 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-22 |
| filingDate |
2013-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e3051a98f894d33ae0a3cee4827ee01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a4483cb3827570aa2b1780c18b29b30 |
| publicationDate |
2013-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013184487-A1 |
| titleOfInvention |
Method to produce a stable dry ionic-bonded creatine alpha ketoglutarate of high oral absorbability |
| abstract |
The invention provides a method to produce a stable, ionic-bonded, dry creatine-α-ketoglutarate product at a molar ratio of about 2:1. The product is stable at room temperature when kept dry for periods of up to one year. The product can be supplemented with additional biologically active, natural amino acid, preferably l-arginine, l-taurine and l-citrulline. The serving dosage is typically between about 1 and 2 g. |
| priorityDate |
2012-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |